143 related articles for article (PubMed ID: 34497436)
1. Association of gene and protein expression and genetic polymorphism of CC chemokine ligand 4 in colorectal cancer.
Shamoun L; Landerholm K; Balboa Ramilo A; Andersson RE; Dimberg J; Wågsäter D
World J Gastroenterol; 2021 Aug; 27(30):5076-5087. PubMed ID: 34497436
[TBL] [Abstract][Full Text] [Related]
2. Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients.
Wågsäter D; Löfgren S; Hugander A; Dienus O; Dimberg J
World J Surg Oncol; 2007 Jul; 5():84. PubMed ID: 17672898
[TBL] [Abstract][Full Text] [Related]
3. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer.
De la Fuente López M; Landskron G; Parada D; Dubois-Camacho K; Simian D; Martinez M; Romero D; Roa JC; Chahuán I; Gutiérrez R; Lopez-K F; Alvarez K; Kronberg U; López S; Sanguinetti A; Moreno N; Abedrapo M; González MJ; Quera R; Hermoso-R MA
Tumour Biol; 2018 Nov; 40(11):1010428318810059. PubMed ID: 30419802
[TBL] [Abstract][Full Text] [Related]
4. Protein Expression and Genetic Variation of
Shamoun L; Kolodziej B; Andersson RE; Dimberg J
Anticancer Res; 2018 Jan; 38(1):321-328. PubMed ID: 29277790
[TBL] [Abstract][Full Text] [Related]
5. Expression and gene polymorphisms of the chemokine CXCL5 in colorectal cancer patients.
Dimberg J; Dienus O; Löfgren S; Hugander A; Wågsäter D
Int J Oncol; 2007 Jul; 31(1):97-102. PubMed ID: 17549409
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5.
Nishikawa G; Kawada K; Nakagawa J; Toda K; Ogawa R; Inamoto S; Mizuno R; Itatani Y; Sakai Y
Cell Death Dis; 2019 Mar; 10(4):264. PubMed ID: 30890699
[TBL] [Abstract][Full Text] [Related]
7. Impact of CCL4 gene polymorphisms and environmental factors on oral cancer development and clinical characteristics.
Lien MY; Lin CW; Tsai HC; Chen YT; Tsai MH; Hua CH; Yang SF; Tang CH
Oncotarget; 2017 May; 8(19):31424-31434. PubMed ID: 28404909
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-β1 gene promoter -509C/T polymorphism in association with expression affects colorectal cancer development and depends on gender.
Stanilova S; Stanilov N; Julianov A; Manolova I; Miteva L
PLoS One; 2018; 13(8):e0201775. PubMed ID: 30071009
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T-lymphocyte Antigen-4 (
VAN Nguyen S; Shamoun L; Landerholm K; Andersson RE; Wagsater D; Dimberg J
In Vivo; 2021; 35(2):969-975. PubMed ID: 33622891
[TBL] [Abstract][Full Text] [Related]
10. Protein expression and gene polymorphism of CXCL10 in patients with colorectal cancer.
Dimberg J; Skarstedt M; Löfgren S; Zar N; Matussek A
Biomed Rep; 2014 May; 2(3):340-343. PubMed ID: 24748971
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of the chemokine CCL21 in human colorectal adenocarcinomas.
Mumtaz M; Wågsäter D; Löfgren S; Hugander A; Zar N; Dimberg J
Oncol Rep; 2009 Jan; 21(1):153-8. PubMed ID: 19082456
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
Dimberg J; Hugander A; Löfgren S; Wågsäter D
Int J Mol Med; 2007 Jan; 19(1):11-5. PubMed ID: 17143542
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic value of CD44 gene polymorphism (rs187115) in Swedish patients with colorectal cancer.
Nguyen SV; Shamoun L; Landerholm K; Wågsäter D; Dimberg J
Nucleosides Nucleotides Nucleic Acids; 2023; 42(10):807-817. PubMed ID: 37074032
[TBL] [Abstract][Full Text] [Related]
14. Correlation between
Hu GN; Tzeng HE; Chen PC; Wang CQ; Zhao YM; Wang Y; Su CM; Tang CH
Int J Med Sci; 2018; 15(11):1179-1186. PubMed ID: 30123055
[TBL] [Abstract][Full Text] [Related]
15. Impact of MTHFR gene C677T polymorphism on Bcl-2 gene methylation and protein expression in colorectal cancer.
Zhu Q; Jin Z; Yuan Y; Lu Q; Ge D; Zong M
Scand J Gastroenterol; 2011 Apr; 46(4):436-45. PubMed ID: 21128871
[TBL] [Abstract][Full Text] [Related]
16. The Association of CCL4 rs1634507 and rs10491121 Polymorphisms with Susceptibility of Oral Squamous Cell Carcinoma in an Iranian Population: A Case-Control Study.
Kadeh H; Eyni M; Parsasefat M; Miri-Moghaddam E
Iran J Pathol; 2022; 17(2):210-216. PubMed ID: 35463731
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients.
Dimberg J; Dienus O; Löfgren S; Hugander A; Wågsäter D
Int J Colorectal Dis; 2007 Oct; 22(10):1195-200. PubMed ID: 17611763
[TBL] [Abstract][Full Text] [Related]
18. Significance of -1082A/G polymorphism of IL10 gene for progression of colorectal cancer and IL-10 expression.
Miteva LD; Stanilov NS; Deliysky TS; Stanilova SA
Tumour Biol; 2014 Dec; 35(12):12655-64. PubMed ID: 25209180
[TBL] [Abstract][Full Text] [Related]
19.
Gao X; Wang X
Nucleosides Nucleotides Nucleic Acids; 2021; 40(8):821-828. PubMed ID: 34284697
[TBL] [Abstract][Full Text] [Related]
20. The influence of PD-L1 genetic variation on the prognosis of R0 resection colorectal cancer patients received capecitabine-based adjuvant chemotherapy: a long-term follow-up, real-world retrospective study.
Su J; Dai B; Yuan W; Wang G; Zhang Z; Li Z; Liu J; Song J
Cancer Chemother Pharmacol; 2020 May; 85(5):969-978. PubMed ID: 32314029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
